BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8445021)

  • 1. C-peptide during the prolonged fast in insulinoma.
    Service FJ; O'Brien PC; McMahon MM; Kao PC
    J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin surrogates in insulinoma.
    O'Brien T; O'Brien PC; Service FJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):448-51. PubMed ID: 8345050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma.
    van Bon AC; Benhadi N; Endert E; Fliers E; Wiersinga WM
    Neth J Med; 2009; 67(7):274-8. PubMed ID: 19687521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
    Nauck MA; Meier JJ
    Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation in insulinoma predicts histopathological tumour characteristics.
    Wolf P; Winhofer Y; Smajis S; Anderwald CH; Scheuba C; Niederle B; Gessl A; Luger A; Krebs M; Koperek O
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):67-71. PubMed ID: 25817061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma.
    Kao PC; Taylor RL; Service FJ
    J Clin Endocrinol Metab; 1994 May; 78(5):1048-51. PubMed ID: 8175958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hyperinsulinaemia at the termination of the prolonged fast.
    Wiesli P; Brändle M; Zapf J; Seiler H; Zwimpfer C; Spinas GA; Schmid C
    Clin Chim Acta; 2004 Apr; 342(1-2):227-31. PubMed ID: 15026285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma.
    Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W
    Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma.
    Service FJ; O'Brien PC; Kao PC; Young WF
    J Clin Endocrinol Metab; 1992 Jan; 74(1):204-10. PubMed ID: 1727822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing serum betahydroxybutyrate concentrations during the 72-hour fast: evidence against hyperinsulinemic hypoglycemia.
    Service FJ; O'Brien PC
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4555-8. PubMed ID: 15886243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of hypoglycemic patients by the glucose clamp technique using the artificial pancreas.
    Pontiroli AE; Secchi A; Dabandi M; Alberetto M; Bosi E; Fantaguzzi S; Pozza G
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1297-300. PubMed ID: 6313737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forty-eight-hour fast: the diagnostic test for insulinoma.
    Hirshberg B; Livi A; Bartlett DL; Libutti SK; Alexander HR; Doppman JL; Skarulis MC; Gorden P
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3222-6. PubMed ID: 10999812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.
    Vezzosi D; Bennet A; Fauvel J; Caron P
    Eur J Endocrinol; 2007 Jul; 157(1):75-83. PubMed ID: 17609405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glucose reduction challenge in the differential diagnosis of fasting hypoglycemia: a two-center study.
    Ipp E; Sinai Y; Forster B; Cortez C; Baroz B; Nesher R; Cerasi E
    J Clin Endocrinol Metab; 1990 Mar; 70(3):711-7. PubMed ID: 2407752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test.
    Li X; Zhang F; Chen H; Yu H; Zhou J; Li M; Li Q; Li L; Yin J; Liu F; Bao Y; Han J; Jia W
    Endocr J; 2017 Jan; 64(1):49-57. PubMed ID: 27725372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratic oscillatory characteristics of plasma insulin concentrations in patients with insulinoma: mechanism for unpredictable hypoglycemia.
    Berman N; Genter P; Chou HF; Cortez C; Bowsher R; Ipp E
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2899-903. PubMed ID: 9284716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
    Nauck M; Stöckmann F; Creutzfeldt W
    Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
    Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
    Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma.
    Pun KK; Young RT; Wang C; Tam CF; Ho PW
    J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic insulinoma in a 10-year-old boy: a case report and literature review.
    Abu-Zaid A; Alghuneim LA; Metawee MT; Elkabbani RO; Almana H; Amin T; Azzam A
    JOP; 2014 Jan; 15(1):53-7. PubMed ID: 24413786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.